GENFIT Pipeline Days - 5 et 19 octobre 2022 – Paris, NYC.
Genfit à la rencontre des investisseurs - Genfit to meet with investors

17 novembre 2022 22 h 00 min
+ de videos
233
Views

GENFIT Pipeline Days – 5 et 19 octobre 2022 – Paris, NYC (sous-titres français)

 

Introduction – Pascal Prigent, Directeur Général

Acute-on chronic liver failure (ACLF)

Disease State – Jonel Trebicka, MD, PhD – Professeur de médecine et chef du service de médecine interne, UKM Uniklinikum Muenster, Allemagne

Disease State – Jennifer C. Lai, MD, MBA – Hépatologue spécialisée dans la transplantation, University of California, UCSF, États-Unis

GENFIT’s Program VS-01-ACLF – Vincent Forster, PhD; Prof. Katharina Staufer, MD

GENFIT’s Program NTZ – Dean Hum, PhD; Carol Addy, MD

Market Opportunity – Back Bay Life Science – Stephen Gauldie, PhD; Mavra Nasir, PhD

Hepatic Encephalopathy (HE)

Disease State – Jonel Trebicka, MD, PhD – Professeur de médecine et chef du service de médecine interne, UKM Uniklinikum Muenster, Allemagne

Disease State – Jennifer C. Lai, MD, MBA – Hépatologue spécialisée dans la transplantation, University of California, UCSF, États-Unis

GENFIT’s Program VS-02-HE – Vincent Forster, PhD; Meriam Kabbaj, PhD

Market Opportunity – Pascal Caisey

Cholangiocarcinoma (CCA)

Disease State – Mark Yarchoan, MD – Professeur associé d’oncologie, John Hopkins Medicine, Baltimore, États-Unis

Disease State – Angela Lamarca, MD – Oncologie Médicale, Fundacion Jimenez Diaz University Hospital, Madrid, Espagne

GENFIT’s Program GNS561 – Dean Hum, PhD; Carol Addy, MD

Market Opportunity – Pascal Caisey

Urea cycle disorder (UCD) & organic acidemia disorder (OAD)

Disease State – Vincent Forster, PhD

GENFIT’s Program VS-01 – Vincent Forster, PhD

Market Opportunity – Pascal Caisey

Conclusion & messages clés

 

GENFIT Pipeline Days – October 5th & 19th, 2022 – Paris, NYC (English subtitles)

Introduction – Pascal Prigent, CEO

Acute-on chronic liver failure (ACLF)

Disease State – Jonel Trebicka, MD, PhD, Professor of Medicine, Chair of Department of Internal Medicine, UKM Uniklinikum Muenster, Germany

Disease State – Jennifer C. Lai, MD, MBA – Transplant Hepatologist, University of California, UCSF, USA

GENFIT’s Program VS-01-ACLF – Vincent Forster, PhD; Prof. Katharina Staufer, MD

GENFIT’s Program NTZ – Dean Hum, PhD; Carol Addy, MD

Market Opportunity – Back Bay Life Science – Stephen Gauldie, PhD; Mavra Nasir, PhD

Hepatic Encephalopathy (HE)

Disease State – Jonel Trebicka, MD, PhD, Professor of Medicine, Chair of Department of Internal Medicine, UKM Uniklinikum Muenster, Germany

Disease State – Jennifer C. Lai, MD, MBA – Transplant Hepatologist, University of California, UCSF, USA

GENFIT’s Program VS-02-HE – Vincent Forster, PhD; Meriam Kabbaj, PhD

Market Opportunity – Pascal Caisey

Cholangiocarcinoma (CCA)

Disease State – Mark Yarchoan, MD, Associate Professor of Oncology at John Hopkins Medicine, Baltimore, USA

Disease State – Angela Lamarca, MD – Medical Oncology, Fundacion Jimenez Diaz University Hospital, Madrid, Spain

GENFIT’s Program GNS561 – Dean Hum, PhD; Carol Addy, MD

Market Opportunity – Pascal Caisey

Urea cycle disorder (UCD) & organic acidemia disorder (OAD)

Disease State – Vincent Forster, PhD

GENFIT’s Program VS-01 – Vincent Forster, PhD

Market Opportunity – Pascal Caisey

Closing remarks & Take-home messages

Les vidéos Genfit déjà diffusées sur ce site sont visibles ici : Vidéos Genfit

Print Friendly, PDF & Email